Insider Transactions in Q1 2024 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2024
|
Bill B Rutherford CFO and EVP |
BUY
Bona fide gift
|
Indirect |
1,194
+5.68%
|
-
|
|
Feb 05
2024
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
1,369
-4.37%
|
-
|
|
Feb 05
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Open market or private sale
|
Direct |
1,645
-17.71%
|
$513,240
$312.0 P/Share
|
|
Feb 03
2024
|
Chad J Wasserman SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-9.11%
|
$11,742
$309.42 P/Share
|
|
Feb 03
2024
|
Chad J Wasserman SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
127
+23.35%
|
-
|
|
Feb 03
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.36%
|
$10,506
$309.42 P/Share
|
|
Feb 03
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
137
+1.45%
|
-
|
|
Feb 02
2024
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
9,652
-37.9%
|
$2,982,468
$309.42 P/Share
|
|
Feb 02
2024
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
19,100
+42.85%
|
$1,317,900
$69.58 P/Share
|
|
Feb 02
2024
|
Chad J Wasserman SVP and CIO |
SELL
Open market or private sale
|
Direct |
652
-69.21%
|
$203,424
$312.04 P/Share
|
|
Feb 02
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
5,127
-35.82%
|
$1,584,243
$309.42 P/Share
|
|
Feb 02
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
6,298
+11.63%
|
$1,423,348
$226.21 P/Share
|
|
Feb 01
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
9,268
-32.08%
|
$2,910,152
$314.66 P/Share
|
|
Feb 01
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
12,994
+11.62%
|
$2,624,788
$202.07 P/Share
|
|
Jan 31
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
3,861
-19.54%
|
$1,185,327
$307.0 P/Share
|
|
Jan 31
2024
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,376
-13.35%
|
$1,938,304
$304.9 P/Share
|
|
Jan 31
2024
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
11,680
+11.16%
|
$1,062,880
$91.56 P/Share
|
|
Jan 31
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,200
-11.38%
|
$979,200
$306.79 P/Share
|
|
Jan 31
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Bona fide gift
|
Direct |
728
-2.52%
|
-
|
|
Jan 29
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-1.18%
|
$27,456
$286.73 P/Share
|
|
Jan 29
2024
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+3.83%
|
-
|
|
Jan 29
2024
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
164
-1.14%
|
$46,904
$286.73 P/Share
|
|
Jan 29
2024
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+4.01%
|
-
|
|
Jan 28
2024
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
SELL
Payment of exercise price or tax liability
|
Direct |
489
-10.86%
|
$138,387
$283.43 P/Share
|
|
Jan 28
2024
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,940
+30.12%
|
-
|